CSN5 specifically interacts with CDK2 and controls senescence in a cytoplasmic cyclin E-mediated manner

por Yoshida, Akihiro, Yoneda-Kato, Noriko, Kato, Jun-ya
Publicado 2013

Chemoprevention curcumin analog 1.1 promotes metaphase arrest and enhances intracellular reactive oxygen species levels on TNBC MDA-MB-231 and HER2-positive HCC1954 cells

por Novitasari, Dhania, Jenie, Riris Istighfari, Kato, Jun-ya, Meiyanto, Edy
Publicado 2023

The COP1 E3-ligase interacts with FIP200, a key regulator of mammalian autophagy

por Kobayashi, Saori, Yoneda-Kato, Noriko, Itahara, Nagisa, Yoshida, Akihiro, Kato, Jun-ya
Publicado 2013

Preclinical evaluation of pentagamavunone-1 as monotherapy and combination therapy for pancreatic cancer in multiple xenograft models

por Kamitani, Naoki, Nakamae, Ikuko, Yoneda-Kato, Noriko, Kato, Jun-ya, Sho, Masayuki
Publicado 2022

CCA-1.1, a Novel Curcumin Analog, Exerts Cytotoxic anti-Migratory Activity toward TNBC and HER2-Enriched Breast Cancer Cells

por Novitasari, Dhania, Jenie, Riris Istighfari, Utomo, Rohmad Yudi, Kato, Jun-ya, Meiyanto, Edy
Publicado 2021

Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth

por Larasati, Yonika Arum, Yoneda-Kato, Noriko, Nakamae, Ikuko, Yokoyama, Takashi, Meiyanto, Edy, Kato, Jun-ya
Publicado 2018

Cell Cycle Modulation of CHO-K1 Cells Under Genistein Treatment Correlates with Cells Senescence, Apoptosis and ROS Level but in a Dose-Dependent Manner

por Jenie, Riris Istighfari, Amalina, Nur Dina, Ilmawati, Gagas Pradani Nur, Utomo, Rohmad Yudi, Ikawati, Muthi, Khumaira, Annisa, Kato, Jun- Ya, Meiyanto, Edy
Publicado 2019

Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence

por Lestari, Beni, Nakamae, Ikuko, Yoneda-Kato, Noriko, Morimoto, Tsumoru, Kanaya, Shigehiko, Yokoyama, Takashi, Shionyu, Masafumi, Shirai, Tsuyoshi, Meiyanto, Edy, Kato, Jun-ya
Publicado 2019

Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties

por Utomo, Rohmad Yudi, Wulandari, Febri, Novitasari, Dhania, Lestari, Beni, Susidarti, Ratna Asmah, Jenie, Riris Istighfari, Kato, Jun-ya, Sardjiman, Sardjiman, Meiyanto, Edy
Publicado 2022

Expression of Cyclin‐dependent Kinase Inhibitor p27/Kipl and AP‐1 Coactivator p38/Jabl Correlates with Differentiation of Embryonal Rhabdomyosarcoma

por Tsuchida, Rika, Miyauchi, Jun, Shen, Lisong, Takagi, Masatoshi, Tsunematsu, Yukiko, Saeki, Morihiro, Honna, Toshiro, Yamada, Seiko, Teraoka, Hirobumi, Kato, Jun‐ya, Mizutani, Shuki
Publicado 2002

Curcumin Derivatives Verify the Essentiality of ROS Upregulation in Tumor Suppression

por Nakamae, Ikuko, Morimoto, Tsumoru, Shima, Hiroki, Shionyu, Masafumi, Fujiki, Hisayo, Yoneda-Kato, Noriko, Yokoyama, Takashi, Kanaya, Shigehiko, Kakiuchi, Kiyomi, Shirai, Tsuyoshi, Meiyanto, Edy, Kato, Jun-ya
Publicado 2019

Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation

por Meiyanto, Edy, Putri, Herwandhani, Arum Larasati, Yonika, Yudi Utomo, Rohmad, Istighfari Jenie, Riris, Ikawati, Muthi, Lestari, Beni, Yoneda-Kato, Noriko, Nakamae, Ikuko, Kawaichi, Masashi, Kato, Jun-Ya
Publicado 2019

The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells

por Meiyanto, Edy, Husnaa, Ulfatul, Kastian, Ria Fajarwati, Putri, Herwandhani, Larasati, Yonika Arum, Khumaira, Annisa, Pamungkas, Dyaningtyas Dewi Putri, Jenie, Riris Istighfari, Kawaichi, Masashi, Lestari, Beni, Yokoyama, Takashi, Kato, Jun-ya
Publicado 2021